Glenmark Life Sciences Ltd IPO- July 27, 2021

Glenmark Life Sciences Ltd IPO- July 27, 2021

All you need to know about the Glenmark Life Sciences Ltd  Rs.1,513 crores initial public offer.

Company Background

Glenmark Life Science Ltd is in the business of making high-quality drugs by unlocking the possibilities of science. Over the years, the company has established strong relationships with leading global generic pharmaceutical companies that have helped them expand their product offerings and geographic reach.

Business Information

The company works with 16 of the 20 largest generic companies globally. With 120 APIs in their portfolio, the company is blending innovation and operational excellence to deliver on the promise of service, reliability, and consistent product quality. Powered by their massive, world-class manufacturing and research capabilities, the company supply high-quality APIs to more than 540 pharma companies in multiple countries.

Facts about the company
  • The company is a research and development (R&D)-driven API manufacturer, focused on undertaking dedicated R&D in their existing products and in areas where they believe there is growth potential in the future.
  • The company believe that maintaining high standards of process innovation and quality in their R&D and manufacturing operations is critical to theirr brand and to developing long-term relationships with their customers.
  • The work that company does spans the entire spectrum of the value chain, from research & development to scale up, manufacturing and delivery. Together, these help the company to support their customers all the way from product identification & development to commercialization and life cycle management.
  • The company cater to chronic therapeutic areas such as cardiovascular disease, central nervous system disorders, pain management and diabetes, among others.

Points to note before investing in Glenmark Life Sciences Ltd IPO
  • From product selection & development to commercialization, they judiciously blend science, technology and economics to stay ahead of the curve
  • Export products in Europe, Latin America, North America, Japan, and the rest of the world
  • Strong relationship with leading global generic companies
  • Proven track record of strong financial performance
  • High-quality product manufacturing with R&D infrastructure.


IPO Opening Date
July 27, 2021
IPO Closing Date
July 29, 2021
Issue Type
Book Built Issue IPO
Face Value
₹2 per equity share
IPO Price
₹695 to ₹720 per equity share
Market Lot
20 Shares
Min Order Quantity
20 Shares
Listing At
BSE, NSE
 
 
​Allotment , Listing and Refunds details

Basis of Allotment Date
August 3, 2021
Initiation of Refunds
August 4, 2021
Credit of Shares to Demat Account
August 5, 2021
IPO Listing Date
August 6, 2021
 
 
Know more-  www.5paisa.com/ipo
 
To apply from 5paisa Website- Apply IPO
 
To apply from 5paisa Mobile App- Apply IPO
 
We hope this information was helpful. For more details, you can post your queries below and we will be happy to share it with you.
 
Thank You!